Company Filing History:
Years Active: 2025
Title: Napon Nilchan: Innovator in Antibody Drug Conjugates
Introduction
Napon Nilchan is a prominent inventor based in Jupiter, Florida. He has made significant contributions to the field of biotechnology, particularly in the development of antibody compounds. His innovative work focuses on enhancing the efficacy of therapeutic applications through advanced antibody drug conjugates.
Latest Patents
Napon Nilchan holds a patent for "Antibody compounds with reactive arginine and related antibody drug conjugates." This invention provides antibody compounds that incorporate a substitution of arginine for the reactive lysine residue (Lys99) in the hydrophobic cleft (38C2_Arg). The patent also details antibody drug conjugate compounds (ADCs) that feature cargo moieties site-specifically conjugated to the engineered arginine residue in the 38C2_Arg variant antibody. The therapeutic applications of these compounds are also highlighted in the patent.
Career Highlights
Napon Nilchan is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to explore and develop groundbreaking technologies in the field of antibody therapeutics. His dedication to research and innovation has positioned him as a key figure in his area of expertise.
Collaborations
Napon has collaborated with notable colleagues, including Christoph Rader and Dobeen Hwang. These partnerships have further enriched his research and contributed to the advancement of antibody drug conjugate technologies.
Conclusion
Napon Nilchan's contributions to the field of biotechnology, particularly through his patent on antibody drug conjugates, demonstrate his commitment to innovation and therapeutic development. His work continues to impact the landscape of medical treatments and showcases the importance of research in advancing healthcare solutions.